ArticleRespiratory research2026
Chronic allergic lung inflammation is associated with brain mast cell-mediated suppression of neuronal activity and behavioral changes in mice.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWe have previously observed depressive-like behaviors in mice following the development of chronic allergic lung inflammation that potentially involved brain mast cell activation. However, the specific brain regions that might be responsible for the observed behavioral changes were not identified. The anterior cingulate cortex (ACC) has been implicated in depression, and hypoactivity of this region is seen in the electroencephalogram of patients with depression. In the current study, we tested our hypothesis that chronic allergic lung inflammation causes mast cell activation that affects neuronal activity in the ACC, leading to depressive-like behavioral changes in mice. We further explored whether preventing mast cell activation during allergen administration modulates neuronal activity and attenuates behavioral changes.
methodsWild-type C57BL/6 J and Thy1-GCaMP6 mice were sensitized with intranasal house dust mite (HDM) antigen or control PBS for 6 weeks to induce chronic allergic lung inflammation. Intraperitoneal injection of cromolyn sodium was performed during HDM sensitization. Neurocognitive tests were carried out before and after the sensitization. In vivo cortical calcium imaging was performed through cranial windows in head-restrained awake mice, and spontaneous calcium activity was measured. Brain and lung tissues were harvested for assessment of inflammatory changes.
resultsCoronal sections of frontal cortex showed that mast cell-derived protease chymase expression was substantially increased in the ACC after 6 weeks of HDM treatment compared with PBS controls. The frequency of somatic calcium activity in ACC pyramidal neurons was reduced in HDM compared with PBS. Intraperitoneal administration of cromolyn sodium, a mast cell stabilizing agent, during HDM sensitization inhibited this frequency reduction observed in HDM sensitized mice. Behavioral changes observed in HDM sensitized mice by open field, light–dark and sucrose preference tests, were attenuated in mice that received cromolyn sodium during HDM sensitization.
conclusionsCerebral mast cell degranulation and decreased somatic calcium activity of pyramidal neurons were observed in the ACC of mice with allergic lung inflammation. Co-administration of mast cell stabilizer cromolyn prevented this allergen-induced hypoactivity and behavioral changes. The activation of mast cells in ACC and decreased pyramidal neuronal activity may play a role in the depressive behaviors observed in mice after chronic HDM sensitization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.